View drug registration information details.
Items | Registration information |
ID | 2097 |
No | 2097 |
Brand Name | OSSIFIX |
Ingredients | CALCIUM CARBONATE USP 1.250 MG EQ.TO ELEMENTAL CALCIUM 500 MG, MAGNESIUM OXIDE USP 50 MG, VITAMINE D3 BP 250 IU, ZINC SULPHATE MONOHYDRATE USP 35 MG, LYSINE HYDROCHLORIDE USP 100MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU-PVC BLISTERPACK |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 10 X 1 X 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | PREDIALYSIS PATIENTS: IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENALFAILURE NOT YET ON DIALYSIS. DIALYSIS PATIENTS: FOR MANAGEMENT OF HYPOCALCEMIA AND THE RESULTANT METABOLIC BONE DISEASE IN PATIENTS UNDERGOING CHRONIC RENAL DIALYSIS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | RED COLOUR OBLONG BICONVEX SHAPED FILM COATED TABLET. ONE SIDE PLAIN AND OTHER SIDE SCORED |
Note | |
License Owner | PALAMY PHARMA CO., LTD |
Manufacturer | ZEE LABOBORATORIES |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 02 I 2732/06 |
FDD Registration Date | 07-FEB-2024 |
Expiry Date | 06-FEB-2027 |
Back to drug list
|